IL-17 and Th17 cells are directly involved in immunity to fungi, with the inhibition of this pathway through -targeted biologics (brodalumab, bimekizumab, ixekizumab and secukinumab) allowing for these infections to take hold [15,16]. The gene discussed is IL17A; the disease is infection.